Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2009

01-04-2009 | Original Article

The Activity of Class I, II, III, and IV Alcohol Dehydrogenase (ADH) Isoenzymes and Aldehyde Dehydrogenase (ALDH) in Esophageal Cancer

Authors: Wojciech Jelski, Miroslaw Kozlowski, Jerzy Laudanski, Jacek Niklinski, Maciej Szmitkowski

Published in: Digestive Diseases and Sciences | Issue 4/2009

Login to get access

Abstract

Background/Aims Ethanol consumption is associated with an increased risk of esophageal cancer. The carcinogenic compound is acetaldehyde, the product of ethanol metabolism. Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) are the main enzymes involved in ethanol metabolism, which leads to generation of acetaldehyde. In this study the activity of ADH isoenzymes and ALDH in esophageal cancer were compared with the activity in normal tissue. Methods For measurement of the activity of class I and II ADH isoenzymes and ALDH activity fluorimetric methods were employed. Total ADH activity and activity of class III and IV isoenzymes was measured by the photometric method. Samples were taken from 59 esophageal cancer patients (27 adenocarcinoma, 32 squamous cell cancer). Results The total activity of ADH and activity of class IV ADH were significantly higher in cancer cells than in healthy tissues. The other tested classes of ADH showed a tendency toward higher activity in cancer than in normal cells. Differences between the activity of enzymes of drinkers and non-drinkers in both cancer and healthy tissue were not significant. Conclusion Increased ADH IV activity may be a factor intensifying carcinogenesis, because of the increased ability to form acetaldehyde from ethanol.
Literature
4.
go back to reference Jornvall H, Hoog JO (1995) Nomenclature of alcohol dehydrogenases. Alcohol Alcohol 30:153–161PubMed Jornvall H, Hoog JO (1995) Nomenclature of alcohol dehydrogenases. Alcohol Alcohol 30:153–161PubMed
7.
go back to reference Yokoyama A, Muramatsu T, Yokoyama T, Matsushita S, Higuchi S, Maruyama K et al (2001) Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis 22:433–439. doi:10.1093/carcin/22.3.433 PubMedCrossRef Yokoyama A, Muramatsu T, Yokoyama T, Matsushita S, Higuchi S, Maruyama K et al (2001) Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis 22:433–439. doi:10.​1093/​carcin/​22.​3.​433 PubMedCrossRef
9.
11.
go back to reference Chrostek L, Jelski W, Szmitkowski M, Puchalski Z (2003) Gender-related differences in hepatic activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in humans. J Clin Lab Anal 17:93–96. doi:10.1002/jcla.10076 PubMedCrossRef Chrostek L, Jelski W, Szmitkowski M, Puchalski Z (2003) Gender-related differences in hepatic activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in humans. J Clin Lab Anal 17:93–96. doi:10.​1002/​jcla.​10076 PubMedCrossRef
14.
go back to reference Lowry OH, Rosebrough NJ, Farr AL (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosebrough NJ, Farr AL (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265–275PubMed
16.
go back to reference Lee CH, Lee JM, Wu DC, Goan YG, Chou SH, Wu IC et al (2008) Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid. Int J Cancer 122:1347–1356. doi:10.1002/ijc.23264 PubMedCrossRef Lee CH, Lee JM, Wu DC, Goan YG, Chou SH, Wu IC et al (2008) Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid. Int J Cancer 122:1347–1356. doi:10.​1002/​ijc.​23264 PubMedCrossRef
18.
Metadata
Title
The Activity of Class I, II, III, and IV Alcohol Dehydrogenase (ADH) Isoenzymes and Aldehyde Dehydrogenase (ALDH) in Esophageal Cancer
Authors
Wojciech Jelski
Miroslaw Kozlowski
Jerzy Laudanski
Jacek Niklinski
Maciej Szmitkowski
Publication date
01-04-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0422-8

Other articles of this Issue 4/2009

Digestive Diseases and Sciences 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine